Home

Orchid Pharma Ltd EPS

Image

Orchid Pharma Ltd

NSE: ORCHPHARMA

EPS

₹ 21.75

Last updated on: Apr 17, 2025

Key Highlights

  • The Earning per Share of Orchid Pharma Ltd is ₹ 21.75 as of 17 Apr 25 .
  • The earning per share of Orchid Pharma Ltd changed from ₹ 1.85 to ₹ 4.1 over 7 quarters. This represents a CAGR of 57.58% .

Historical Earning per Share of Orchid Pharma Ltd

No data available

* All values are in

Company Fundamentals for Orchid Pharma Ltd

Market Cap

3,932 Cr

EPS

21.8

P/E Ratio (TTM)

35.7

P/B Ratio (TTM)

3.2

Day’s High

798.0

Day’s Low

761.75

DTE

0.1

ROE

9.7

52 Week High

1998.0

52 Week Low

670.05

ROCE

9.2

Market Price of Orchid Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Orchid Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
17 Apr 2025775.3
16 Apr 2025777.35
15 Apr 2025755.35
11 Apr 2025719.4
09 Apr 2025705.3
08 Apr 2025701.2
07 Apr 2025720.6
04 Apr 2025757.5
03 Apr 2025797.35
02 Apr 2025795.8

SWOT Analysis Of Orchid Pharma Ltd

Strength

3

che

Weakness

2

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Orchid Pharma Ltd

Asset Value vs Market Value of Orchid Pharma Ltd

Market Value

3,932

Asset Value

Value addition

4.0 X

791

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Orchid Pharma Ltd3932
Sun Pharmaceutical Industries Ltd420136
Divis Laboratories Ltd149680
Cipla Ltd122390
Torrent Pharmaceuticals Ltd110154
Mankind Pharma Ltd106555

Historical Market Cap of Orchid Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Orchid Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Orchid Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Orchid Pharma Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Orchid Pharma Ltd News Hub

Orchid Pharma consolidated net profit rises 212.23% in the June 2024 quarter

Net profit of Orchid Pharma rose 212.23% to Rs 29.35 crore in the quarter ended June 2024 as against

Read more

13 Aug 24

Orchid Pharma announces board meeting date

Orchid Pharma will hold a meeting of the Board of Directors of the Company on 12 August 2024. Powere

Read more

10 Aug 24

Orchid Pharma to hold board meeting

Orchid Pharma will hold a meeting of the Board of Directors of the Company on 11 November 2024 Power

Read more

06 Nov 24

Orchid Pharma consolidated net profit rises 37.58% in the September 2024 quarter

Net profit of Orchid Pharma rose 37.58% to Rs 27.24 crore in the quarter ended September 2024 as aga

Read more

11 Nov 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Orchid Pharma Ltd

What is the EPS of Orchid Pharma Ltd stock?

The Earnings Per Share (EPS) of Orchid Pharma Ltd is 21.75. An EPS is the amount of net income attributed to each share of a common stock.

How is Orchid Pharma Ltd EPS calculated?

The EPS of Orchid Pharma Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Orchid Pharma Ltd report its EPS?

Orchid Pharma Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Orchid Pharma Ltd EPS?

Factors that influence the EPS of Orchid Pharma Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Orchid Pharma Ltd EPS growth indicate future performance?

Yes, consistent growth in Orchid Pharma Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions